This appeal requires us to decide whether ERISA pre-empts a state-law malpractice action brought by the beneficiary of an ERISA plan against a company that provides “utilization review” services to the plan. We also address the availability under ERISA of extracontractual damages. The district court granted the defendants’ motion for summary judgment, holding that ERISA both pre-empted the plaintiffs’ medical malpractice claim and precluded them from recovering emotional distress damages. We affirm.
I. BACKGROUND
The basic facts are undisputed. Florence Corcoran, a long-time employee of South Central Bell Telephone Company (Bell), became pregnant in early 1989. In July, her obstetrician, Dr. Jason Collins, recommended that she have complete bed rest during the final months of her pregnancy. Mrs. Corcoran applied to Bell for temporary disability benefits for the remainder of her pregnancy, but the benefits were denied. This prompted Dr. Collins to write to Dr. Theodore J. Borgman, medical consultant for Bell, and explain that Mrs. Cor-coran had several medical problems which placed her “in a category of high risk pregnancy.” Bell again denied disability benefits. Unbeknownst to Mrs. Corcoran or Dr. Collins, Dr. Borgman solicited a second opinion on Mrs. Corcoran’s condition from another obstetrician, Dr. Simon Ward. In a letter to Dr. Borgman, Dr. Ward indicated that he had reviewed Mrs. Corcoran’s medical records and suggested that “the company would be at considerable risk denying her doctor's recommendation.” As Mrs. Corcoran neared her delivery date, Dr. Collins ordered her hospitalized so that *1323 he could monitor the fetus around the clock. 1
Mrs. Corcoran was a member of Bell’s Medical Assistance Plan (MAP or “the Plan”). MAP is a self-funded welfare benefit plan which provides medical benefits to eligible Bell employees. It is administered by defendant Blue Cross and Blue Shield of Alabama (Blue Cross) pursuant to an Administrative Services Agreement between Bell and Blue Cross. The parties agree that it is governed by ERISA. 2 Under a portion of the Plan known as the “Quality Care Program” (QCP), participants must obtain advance approval for overnight hospital admissions and certain medical procedures (“pre-certification”), and must obtain approval on a continuing basis once they are admitted to a hospital (“concurrent review”), or plan benefits to which they otherwise would be entitled are reduced.
QCP is administered by defendant United Healthcare (United) pursuant to an agreement with Bell. United performs a form of cost-containment service that has commonly become known as “utilization review.” See Blum, An Analysis of Legal Liability in Health Care Utilization Review and Case Management, 26 Hous.L.Rev. 191, 192-93 (1989) (Utilization review refers to “external evaluations that are based on established clinical criteria and are conducted by third-party payors, purchasers, or health care organizers to evaluate the appropriateness of an episode, or series of episodes, of medical care.”). The Summary Plan Description (SPD) explains QCP as follows:
The Quality Care Program (QCP), administered by United HealthCare, Inc., assists you and your covered dependents in securing quality medical care according to the provisions of the Plan while helping reduce risk and expense due to unnecessary hospitalization and surgery. They do this by providing you with information which will permit you (in consultation with your doctor) to evaluate alternatives to surgery and hospitalization when those alternatives are medically appropriate. In addition, QCP will monitor any certified hospital confinement to keep you informed as to whether or not the stay is covered by the Plan.
Two paragraphs below, the SPD contains this statement: When reading this booklet, remember that all decisions regarding your medical care are up to you and your doctor. It goes on to explain that when a beneficiary does not contact United or follow its pre-certification decision, a “QCP Penalty” is applied. The penalty involves reduction of benefits by 20 percent for the remainder of the calendar year or until the annual out-of-pocket limit is reached. Moreover, the annual out-of-pocket limit is increased from $1,000 to $1,250 in covered expenses, not including any applicable deductible. According to the QCP Administrative Manual, the QCP penalty is automatically applied when a participant fails to contact United. However, if a participant complies with QCP by contacting United, but does not follow its decision, the penalty may be waived following an internal appeal if the medical facts show that the treatment chosen was appropriate.
A more complete description of QCP and the services provided by United is contained in a separate booklet. Under the heading “WHAT QCP DOES” the booklet explains:
Whenever your doctor recommends surgery or hospitalization for you or a covered dependent, QCP will provide an independent review of your condition (or your covered dependent’s). The purpose of the review is to assess the need for surgery or hospitalization and to determine the appropriate length of stay for a hospitalization, based on nationally accepted medical guidelines. As part of *1324 the review process, QCP will discuss with your doctor the appropriateness of the treatments recommended and the availability of alternative types of treatments — or locations for treatment — that are equally effective, involve less risk, and are more cost effective.
The next paragraph is headed “INDEPENDENT, PROFESSIONAL REVIEW” and states:
United Health Care, an independent professional medical review organization, has been engaged to provide services under QCP. United’s staff includes doctors, nurses, and other medical professionals knowledgeable about the health care delivery system. Together with your doctor, they work to assure that you and your covered family members receive the most appropriate medical care.
At several points in the booklet, the themes of “independent medical review” and “reduction of unnecessary risk and expense” are repeated. Under a section entitled “THE QUALITY CARE PROGRAM ... AT A GLANCE” the booklet states that QCP “Provides independent, professional review when surgery or hospitalization is recommended — to assist you in making an enlightened decision regarding your treatment.” QCP “[pjrovides improved quality of care by eliminating medically unnecessary treatment,” but beneficiaries who fail to use it “may be exposed to unnecessary health risks.... ” Elsewhere, in the course of pointing out that studies show one-third of all surgery may be unnecessary, the booklet explains that programs such as QCP “help reduce unnecessary and inappropriate care and eliminate their associated costs.” Thus, “one important service of QCP will help you get a second opinion when your doctor recommends surgery.”
The booklet goes on to describe the circumstances under which QCP must be utilized. When a Plan member’s doctor recommends admission to the hospital, [i]ndependent medical professionals will review, with the patient’s doctor, the medical findings and the proposed course of treatment, including the medically necessary length of confinement. The Quality Care Program may require additional tests or information (including second opinions), when determined necessary during consultation between QCP professionals and the attending physician.
When United certifies a hospital stay, it monitors the continuing necessity of the stay. It also determines, for certain medical procedures and surgeries, whether a second opinion is necessary, and authorizes, where appropriate, certain alternative forms of care. Beneficiaries are strongly encouraged to use QCP to avoid loss of benefits: “ ‘fully using' QCP means following the course of treatment that’s recommended by QCP’s medical professionals.”
In accordance with the QCP portion of the plan, Dr. Collins sought pre-certification from United for Mrs. Corcoran’s hospital stay. Despite Dr. Collins's recommendation, United determined that hospitalization was not necessary, and instead authorized 10 hours per day of home nursing care. 3 Mrs. Corcoran entered the hospital on October 3, 1989, but, because United had not pre-certified her stay, she returned home on October 12. On October 25, during a period of time when no nurse was on duty, the fetus went into distress and died.
Mrs. Corcoran and her husband, Wayne, filed a wrongful death action in Louisiana state court alleging that their unborn child died as a result of various acts of negligence committed by Blue Cross and United. Both sought damages for the lost love, society and affection of their unborn child. In addition, Mrs. Corcoran sought damages for the aggravation of a pre-existing depressive condition and the loss of consortium caused by such aggravation, and Mr. Corcoran sought damages for loss of consortium. The defendants removed the action to federal court on grounds that it was *1325 pre-empted by ERISA 4 and that there was complete diversity among the parties.
Shortly thereafter, the defendants moved for summary judgment. They argued that the Corcorans’ cause of action, properly characterized, sought damages for improper handling of a claim from two entities whose responsibilities were simply to administer benefits under an ERISA-governed plan. They contended that their relationship to Mrs. Corcoran came into existence solely as a result of an ERISA plan and was defined entirely by the plan. Thus, they urged the court to view the claims as “relating to” an ERISA plan, and therefore within the broad scope of state law claims pre-empted by the statute. In their opposition to the motion, the Corcor-ans argued that “[t]his case essentially boils down to one for malpractice against United HealthCare....” They contended that under this court’s analysis in
Sommers Drug Stores Co. Employee Profit Sharing Trust v. Corrigan Enterprises, Inc.,
The district court, relying on the broad ERISA pre-emption principles developed by the Supreme Court and the Fifth Circuit, granted the motion. The court noted that ERISA pre-emption extends to state law claims “ ‘of general application,’ including tort claims where ERISA ordinarily plays no role in the state law at issue.” (citing
Metropolitan Life Ins. Co. v. Taylor,
[b]ut for the ERISA plan, the defendants would have played no role in Mrs. Cor-coran’s pregnancy; the sole reason the defendants had anything to do with her pregnancy is because the terms of the ERISA plan directed Mrs. Corcoran to the defendants (or at least to United HealthCare) for approval of coverage of the medical care she initially sought.
The court held that, because the ERISA plan was the source of the relationship between the Corcorans and the defendants, the Corcorans’ attempt to distinguish United’s role in paying claims from its role as a source of professional medical advice was unconvincing.
The Corcorans filed a motion for reconsideration under Rule 59 of the Federal Rules of Civil Procedure. They did not ask the district court to reconsider its pre-emption ruling, but instead contended that language in the district court’s opinion had implicitly recognized that they had a separate cause of action under ERISA’s civil enforcement mechanism, § 502(a)(3).
5
They argued that the Supreme Court’s decision in
Massachusetts Mutual Life Ins. Co. v. Russell,
II. STANDARD OF REVIEW
Because this case is on appeal from the district court’s grant of summary judgment, our review is plenary.
Dorsett v. Board of Trustees for State Colleges & Universities,
ill. PRE-EMPTION OF THE STATE LAW CAUSE OF ACTION
A. The Nature of the Corcorans’ State Law Claims
The Corcorans’ original petition in state court alleged that acts of negligence committed by Blue Cross and United caused the death of their unborn child. Specifically, they alleged that Blue Cross wrongfully denied appropriate medical care, failed adequately to oversee the medical decisions of United, and failed to provide United with Mrs. Corcoran’s complete medical background. They alleged that United wrongfully denied the medical care recommended by Dr. Collins and wrongfully determined that home nursing care was adequate for her condition. It is evident that the Corcor-ans no longer pursue any theory of recovery against Blue Cross. Although they mention in their appellate brief the fact that they asserted a claim against Blue Cross, they challenge only the district court’s conclusion that ERISA pre-empts their state law cause of action against United.
6
We, therefore, analyze solely the question of pre-emption of the claims against United.
See Hulsey v. State of Texas,
The claims against United arise from a relatively recent phenomenon in the health care delivery system — the prospective review by a third party of the necessity of medical care. Systems of prospective and concurrent review, rather than traditional retrospective review, were widely adopted throughout the 1980s as a method of containing the rapidly rising costs of health care. Blum, supra, at 192; Furrow, Medical Malpractice and Cost Containment: Tightening the Screws, 36 Case Western L.Rev. 985, 986-87 (1986). Under the traditional retrospective system (also commonly known as the fee-for-service system), the patient obtained medical treatment and the insurer reviewed the provider’s claims for payment to determine whether they were *1327 covered under the plan. Denial of a claim meant that the cost of treatment was absorbed by an entity other than the one designed to spread the risk of medical costs — the insurer.
Congress’s adoption in 1983 of a system under which hospitals are reimbursed for services provided to Medicare patients based upon average cost calculations for patients with particular diagnoses spurred private insurers to institute similar programs in which prospective décisions are made about the appropriate level of care. Although plans vary, the typical prospective review system requires some form of pre-admission certification by a third party (e.g., the HMO if an HMO-associated doctor provides care; an outside organization such as United if an independent physician provides care) before a hospital stay. Concurrent review involves the monitoring of a hospital stay to determine its continuing appropriateness. See generally, Blum, supra, at 192-93; Tiano, The Legal Implications of HMO Cost Containment Measures, 14 Seton Hall Legis.J. 79, 80 (1990). As the SPD makes clear, United performs this sort of prospective and concurrent review (generically, “utilization review”) in connection with, inter alia, the hospitalization of Bell employees.
The Corcorans based their action against United on Article 2315 of the Louisiana Civil Code, which provides that “[e]very act whatever of man that causes damage to another obliges him by whose fault it happened to repair it.” Article 2315 provides parents with a cause of action for the wrongful death of their unborn children,
Danos v. St. Pierre,
*1328
In the absence of clear Louisiana authority for their lawsuit, the Corcorans rely on
Green v. Walker,
B. Principles of ERISA Pre-emption
The central inquiry in determining whether a federal statute pre-empts state law is the intent of Congress.
FMC Corp. v. Holliday,
— U.S. -,
ERISA contains an explicit pre-emption clause, which provides, in relevant part:
Except as provided in subsection (b) of this section,' the provisions of this sub-chapter and subchapter III of this chapter shall supersede any and all State laws insofar as they may now or hereafter relate to any employee benefit plan described in section 1003(a)....
ERISA § 514(a).
10
It is by now well-established that the “deliberately expansive” language of this clause,
Pilot Life Ins. Co. v. Dedeaux,
The most obvious class of pre-empted state laws are those that are specifically designed to affect ERISA-governed employee benefit plans.
See Mackey v. Lanier Collection Agency & Serv., Inc.,
C. Pre-emption of the Corcorans’ Claims
Initially, we observe that the common law causes of action advanced by the Corcorans are not that species of law “specifically designed” to affect ERISA plans, for the liability rules they seek to invoke neither make explicit reference to nor are premised on the existence of an ERISA plan.
See Ingersoll-Rand,
1. United’s position — it makes benefit determinations, not medical decisions
United’s argument in favor of pre-emption is grounded in the notion that the decision it made concerning Mrs. Corcoran was not primarily a medical decision, but instead was a decision made in its capacity as a plan fiduciary about what benefits were authorized under the Plan. All it did, it argues, was determine whether Mrs. Cor-coran qualified for the benefits provided by the plan by applying previously established eligibility criteria. The argument’s coup de grace is that under well-established prece *1330 dent, 12 participants may not sue in tort to redress injuries flowing from decisions about what benefits are to be paid under a plan. One commentator has endorsed this view of lawsuits against providers of utilization review services, arguing that, because medical services are the “benefits” provided by a utilization review company, complaints about the quality of medical services (i.e., lawsuits for negligence) “can therefore be characterized as claims founded upon a constructive denial of plan benefits.” Chittenden, Malpractice Liability and Managed Health Care: History & Prognosis, 26 Tort & Ins. Law J. 451, 489 (1991).
In support of its argument, United points to its explanatory booklet and its language stating that the company advises the patient’s doctor “what the medical plan will pay for, based on a review of [the patient’s] clinical information and nationally accepted medical guidelines for the treatment of [the patient’s] condition.” It also relies on statements to the effect that the ultimate medical decisions are up to the beneficiary’s doctor. It acknowledges at various points that its decision about what benefits would be paid was based on a consideration of medical information, but the thrust of the argument is that it was simply performing commonplace administrative duties akin to claims handling.
Because it was merely performing claims handling functions when it rejected Dr. Collins’s request to approve Mrs. Corcoran’s hospitalization, United contends, the principles of
Pilot Life
and its progeny squarely foreclose this lawsuit. In
Pilot Life,
a beneficiary sought damages under various state-law tort and contract theories from the insurance company that determined eligibility for the employer’s long term disability benefit plan. The company had paid benefits for two years, but there followed a period during which the company terminated and reinstated the beneficiary several times.
2. The Corcorans’ position — United makes medical decisions, not benefit determinations
The Corcorans assert that Pilot Life and its progeny are inapposite because they are not advancing a claim for improper processing of benefits. Rather, they say, they seek to recover solely for United’s erroneous medical decision that Mrs. Corcoran did not require hospitalization during the last month of her pregnancy. This argument, of course, depends on viewing United’s action in this case as a medical decision, and not merely an administrative determination about benefit entitlements. Accordingly, the Corcorans, pointing to the statements United makes in the QCP booklet concerning its medical expertise, contend that United exercised medical judgment which is outside the purview of ERISA pre-emption.
The Corcorans suggest that a medical negligence claim is permitted under the analytical framework we have developed for assessing pre-emption claims. Relying on
Sommers Drug Stores Co. Employee Profit Sharing Trust v. Corrigan Enterprises, Inc.,
*1331 3. Our view — United makes medical decisions incident to benefit determinations
We cannot fully agree with either United or the Corcorans. Ultimately, we conclude that United makes medical decisions — indeed, United gives medical advice — but it does so in the context of making a determination about the availability of benefits under the plan. Accordingly, we hold that the Louisiana tort action asserted by the Corcorans for the wrongful death of their child allegedly resulting from United’s erroneous medical decision is pre-empted by ERISA.
Turning first to the question of the characterization of United’s actions, we note that the QCP booklet and the SPD lend substantial support to the Corcorans’ argument that United makes medical decisions. United’s own booklet tells beneficiaries that it “assesses] the need for surgery or hospitalization and ... determine^] the appropriate length of stay for a hospitalization, based on nationally accepted medical guidelines.” United “will discuss with your doctor the appropriateness of the treatments recommended and the availability of alternative types of treatments.” Further, “United’s staff includes doctors, nurses, and other medical professionals knowledgeable about the health care delivery system. Together with your doctor, they work to assure that you and your covered family members receive the most appropriate medical care.” According to the SPD, United will “provid[e] you with information which will permit you (in consultation with your doctor) to evaluate alternatives to surgery and hospitalization when those alternatives are medically appropriate.”
United makes much of the disclaimer that decisions about medical care are up to the beneficiary and his or her doctor. While that may be so, and while the disclaimer may support the conclusion that the relationship between United and the beneficiary is not that of doctor-patient, it does not mean that United does not make medical decisions or dispense medical advice.
See Wickline,
United argues that the decision it makes in this, the prospective context, is no different than the decision an insurer makes in the traditional retrospective context. The question in each case is “what the medical plan will pay for, based on a review of [the beneficiary’s] clinical information and nationally accepted medical guidelines for the treatment of [the beneficiary’s] condition.” See QCP Booklet at 4. A prospective decision is, however, different in its impact on the beneficiary than a retrospective decision. In both systems, the beneficiary theoretically knows in advance what treat *1332 ments the plan will pay for because coverage is spelled out in the plan documents. But in the retrospective system, a beneficiary who embarks on the course of treatment recommended by his or her physician has only a potential risk of disallowance of all or a part of the cost of that treatment, and then only after treatment has been rendered. In contrast, in a prospective system a beneficiary may be squarely presented in advance of treatment with a statement that the insurer will not pay for the proposed course of treatment recommended by his or her doctor and the beneficiary has the potential of recovering the cost of that treatment only if he or she can prevail in a challenge to the insurer’s decision. A beneficiary in the latter system would likely be far less inclined to undertake the course of treatment that the insurer has at least preliminarily rejected.
By its very nature, a system of prospective decisionmaking influences the beneficiary’s choice among treatment options to a far greater degree than does the theoretical risk of disallowance of a claim facing a beneficiary in a retrospective system. Indeed, the perception among insurers that prospective determinations result in lower health care costs is premised on the likelihood that a beneficiary, faced with the knowledge of specifically what the plan will and will not pay for, will choose the treatment option recommended by the plan in order to avoid risking total or partial disallowance of benefits. When United makes a decision pursuant to QCP, it is making a medical recommendation which— because of the financial ramifications — is more likely to be followed. 14
Although we disagree with United's position that no part of its actions involves medical decisions, we cannot agree with the Corcorans that no part of United’s actions involves benefit determinations. In our view, United makes medical decisions as part and parcel of its mandate to decide what benefits are available under the Bell plan. As the QCP Booklet concisely puts it, United decides “what the medical plan will pay for.” When United’s actions are viewed from this perspective, it becomes apparent that the Corcorans are attempting to recover for a tort allegedly committed in the course of handling a benefit determination. The nature of the benefit determination is different than the type of decision that was at issue in Pilot Life, but it is a benefit determination nonetheless. The principle of Pilot Life that ERISA preempts state-law claims alleging improper handling of benefit claims is broad enough to cover the cause of action asserted here.
Moreover, allowing the Corcorans’ suit to go forward would contravene Congress’s goals of “ensur[ing] that plans and plan sponsors would be subject to a uniform body of benefit law” and “minimiz[ing] the administrative and financial burdens of complying with conflicting directives among States or between States and the Federal Government.”
Ingersoll-Rand Co.,
It is foreseeable that state courts, exercising their common law powers, might develop different substantive standards applicable to the same employer conduct, requiring the tailoring of plans and employer conduct to the peculiarities of the law of each jurisdiction. Such an outcome is fundamentally at odds with the goal of uniformity that Congress sought to implement.
Ill S.Ct. at 484. Similarly, although imposing liability on United might have the salutary effect of deterring poor quality medical decisions, 15 there is a significant risk that state liability rules would be applied differently to the conduct of utilization review companies in different states. The cost of complying with varying substantive standards would increase the cost of providing utilization review services, thereby increasing the cost to health benefit plans of including cost containment features such as the Quality Care Program (or causing them to eliminate this sort of cost containment program altogether) and ultimately decreasing the pool of plan funds available to reimburse participants. See Macaulay, supra, at 105. 16
It may be true, as the Corcorans assert, that Louisiana tort law places duties on persons who make medical judgments within the state, and the Louisiana courts may one day recognize that this duty extends to the medical decisions made by utilization review companies. But it is equally true that Congress may pre-empt state-law causes of action which seek to enforce various duties when it determines that such actions would interfere with a carefully constructed scheme of federal regulation.
See Pilot Life,
We are not persuaded that
Sommers Drug,
on which the Corcorans rely heavily, commands a different outcome. In
Som-mers Drug,
we observed that courts are less likely to find pre-emption when the state law involves an exercise of traditional state authority than when the law affects an area not traditionally regulated by the states.
Id.
at 1467. The Corcorans contend that they easily pass this hurdle, as tort law traditionally has been reserved to the states, but this victory only puts them back at the starting line again. We went on to say in
Sommers Drug
that we were “not convinced” that the traditional or nontraditional nature of the state law properly bears upon the initial question whether it is pre-empted by § 514(a), because the distinction had no support in the statutory language.
Id.
at 1468. We continue to adhere to this view. As cases such as
Inger-soll-Rand
and
Christopher
illustrate, the fact that states traditionally have regulated in a particular area has functioned as no impediment to ERISA pre-emption.
See Ingersoll-Rand,
The second factor identified in
Sommers Drug
as bearing on pre-emption — whether the state law affects relations among principal ERISA entities — continues to be relevant in this circuit,
see Memorial Hosp.,
IV. EXTRACONTRACTUAL DAMAGES
The Corcorans argue in the alternative that the damages they seek are available as “other appropriate equitable relief” under ERISA § 502(a)(3). That section provides:
(a) A civil action may be brought—
(3) by a participant, beneficiary, or fiduciary (A) to enjoin any act or practice which violates any provision of this subchapter or the terms of the plan, or (B) to obtain other appropriate equitable relief (i) to redress such violations or (ii) to enforce any provisions of this subchapter or the terms of the plan; ...
*1335 Although the Corcorans did not assert a cause of action under § 502(a)(3) in their original state court complaint, they asked the district court in their motion for reconsideration to award damages pursuant to this section. The defendants agreed at oral argument that the issue was properly raised and preserved for appeal, and we proceed to consider it.
Section 502(a)(3) provides for relief apart from an award of benefits due under the terms of a plan. When a beneficiary simply wants what was supposed to have been distributed under the plan, the appropriate remedy is § 502(a)(1)(B).
See, e.g., Cathey v. Dow Chemical Co. Medical Care Program,
The question whether extracontractual or punitive damages are available to a beneficiary under § 502(a)(3) has been left open by the Supreme Court ever since
Massachusetts Mutual Life Insurance Co. v. Russell,
In a concurrence joined by three other Justices, Justice Brennan emphasized that he read the Court’s reasoning to apply only to § 409(a), and that the legislative history of ERISA suggested that courts should develop a federal common law in fashioning “other appropriate equitable relief” under § 502(a)(3).
Id.
at 155-56,
The Corcorans urge us to apply Justice Brennan’s concurrence and hold that the damages they seek amount to “other appropriate equitable relief.” The defendants, on the other hand, urge us to interpret “other appropriate equitable relief” to include only declaratory and injunctive relief. Under the defendants’ view of § 502(a)(3), which has been adopted by a number of circuits, 18 no money damages would be awardable and our discussion would be at an end. However, even assuming that Justice Brennan’s view of “other appropriate equitable relief” as potentially encompassing make-whole relief is a proper construction of that section, the damages the Corcorans seek would not be available.
The characterization of equitable relief as encompassing damages necessary to make the plaintiff whole may well be consistent with the trust law principles that were incorporated into ERISA and which guide its interpretation.
See Firestone,
This view may also be consistent with the common law contract doctrine which assists us in interpreting ERISA. As the Court observed in
Russell,
ERISA was enacted “to protect contractually defined benefits.”
However, the Corcorans seek a form of extracontractual damages that is never, as far as we can tell, awarded for breach of trust duties, and is granted only in the most limited of circumstances for a breach of contract. Certainly, patients and their physicians can enter into contracts and physicians may incur liability for breach. The cases are uniform, however, in holding that there can be no recovery against a physician on a contractual theory, as opposed to the usual recovery on a tort theory of medical negligence, unless there is an express agreement to perform a particular service or to achieve a specific cure.
E.g., Bobrick v. Bravstein,
The strictness with which courts have viewed doctor-patient contracts thwarts the Corcorans’ claim that emotional distress damages would be available here under a make-whole interpretation of § 502(a)(3). The existence of a true doctor-patient relationship between Mrs. Corcoran and United which could support a contractual theory of recovery is dubious at best. Related to this problem is the lack of an express agreement for a particular service or for a particular result that serves as a prerequisite to a contract-based recovery. Even assuming that United’s booklet could be considered an aspect of the “plan,” breach of which would give rise to a cause of action under § 502(a)(3), it cannot be construed as making an agreement to perform any particular medical procedure or to arrive at any result. At most it makes promises to act in accordance with accepted standards of medical care. But courts have not recognized these sorts of promises as creating contractual duties between physicians and patients.
Cirafici,
The fact that courts regularly view doctors and their patients as standing in a fiduciary relationship,
e.g., Black v. Littlejohn,
The result ERISA compels us to reach means that the Corcorans have no remedy, state or federal, for what may have been a serious mistake. This is troubling for several reasons. First, it eliminates an important check on the thousands of medical decisions routinely made in the burgeoning utilization review system. With liability rules generally inapplicable, there is theoretically less deterrence of substandard medical decisionmaking. Moreover, if the cost of compliance with a standard of care (reflected either in the cost of prevention or the cost of paying judgments) need not be factored into utilization review companies’ cost of doing business, bad medical judgments will end up being cost-free to the plans that rely on these companies to contain medical costs. 20 ERISA plans, in turn, will have one less incentive to seek out the companies that can deliver both high quality services and reasonable prices.
Second, in any plan benefit determination, there is always some tension between the interest of the beneficiary in obtaining quality medical care and the interest of the plan in preserving the pool of funds available to compensate all beneficiaries. In a prospective review context, with its greatly increased ability to deter the beneficiary (correctly or not) from embarking on a course of treatment recommended by the beneficiary’s physician, the tension between interest of the beneficiary and that of the plan is exacerbated. A system which would, at least in some circumstances, compensate the beneficiary who changes course based upon a wrong call for the costs of that call might ease the tension between the conflicting interests of the beneficiary and the plan.
Finally, cost containment features such as the one at issue in this case did not exist when Congress passed ERISA. While we are confident that the result we have reached is faithful to Congress’s intent neither to allow state-law causes of action that relate to employee benefit plans nor to provide beneficiaries in the Corcorans’ position with a remedy under ERISA, the world of employee benefit plans has hardly remained static since 1974. Fundamental changes such as the widespread institution of utilization review would seem to warrant a reevaluation of ERISA so that it can continue to serve its noble purpose of safeguarding the interests of employees. Our *1339-1347 system, of course, allocates this task to Congress, not the courts, and we acknowledge our role today by interpreting ERISA in a manner consistent with the expressed intentions of its creators.
V. CONCLUSION
For all the foregoing reasons, we find that ERISA pre-empts the Corcorans’ tort claim against United and that the Corcor-ans may not recover damages for emotional distress under § 502(a)(3) of ERISA. Accordingly, the judgment of the district court is AFFIRMED.
Notes
. This was the same course of action Dr. Collins had ordered during Mrs. Corcoran’s 1988 pregnancy. In that pregnancy, Dr. Collins intervened and performed a successful Caesarean section in the 36th week when the fetus went into distress.
. Employee Retirement Income Security Act of 1974, Pub.L. No. 93-406, 88 Stat. 829, 29 U.S.C. §§ 1001-1461.
. The record does not reveal the name of the person or persons at United that made the decision concerning Mrs. Corcoran.
.
See Metropolitan Life Ins. Co. v. Taylor,
. The district court had stated that "[bjecause the plaintiffs concede that the defendants have fully paid any and all medical expenses that Mrs. Corcoran actually incurred that were covered by the plan, the plaintiffs have no remaining claims under ERISA.” In a footnote, the court indicated that Mrs. Corcoran could have (1) sued under ERISA, before entering the hospital, for a declaratory judgment that she was entitled to hospitalization benefits; or (2) gone into the hospital, incurred out-of-pocket expenses, and sued under ERISA for these expenses.
. They also do not mention Blue Cross when arguing that extracontractual damages are available under § 502(a)(3).
. The case went to trial, but the plaintiff settled with Western Medical, the provider of utilization review services. See Milt Freudenheim, When Treatment and Costs Collide, N.Y. Times, Apr. 28, 1992, at C2 col. 1.
. Numerous commentators have weighed in on the propriety of liability for utilization review decisions. See, e.g., Macaulay, Health Care Cost Containment and Medical Malpractice: On a Collision Course, 19 Suffolk U.L.Rev. 91, 106-07 (1986) (arguing for higher standard of negligence in "Wickline suits”); Morreim, Cost Containment and the Standard of Medical Care, 75 Calif .L.Rev. 1719, 1749-50 (1987) (arguing that liability should be limited because patient's physician makes the ultimate decision about treatment); Note, Paying the Piper: Third Party Pay- or Liability for Medical Treatment Decisions, 25 Ga.L.Rev. 861, 907-11 (1991) (by David Griner) (arguing that without liability for negligence in utilization review decisions, third party payors have incentives to control costs but not to use reasonable care in the decisionmaking process); Mellas, Adapting the Judicial Approach to Medical Malpractice Claims Against Physicians to Reflect Medicare Cost Containment Measures, 62 U.Colo.L.Rev. 287, 316 (1991) (liability will reduce possibility that poor medical decisions will be made in order to cut costs).
Even if courts put their imprimatur on negligence actions against utilization review organizations, plaintiffs would face difficulties in proving that the organization’s decision was a significant cause of an injury.
See Wickline,
. If the Corcorans could sue United on a negligence theory, it would appear that they could recover damages incurred in connection with the death of their unborn child.
Danos,
. Statutory, decisional and all other forms of state law are included within the scope of the preemption clause. ERISA § 514(c)(1) ("The term ‘State law’ includes all laws, decisions, rules, regulations, or other State action having the effect of law, of any State”). Section 514(b)(2)(A) exempts certain state laws from pre-emption, but none of these exemptions is applicable here.
. The legislative history indicates that Congress intended the preemption provision to be applied expansively. In
Shaw v. Delta Air Lines, Inc.,
The bill that became ERISA originally contained a limited pre-emption clause, applicable only to state laws relating to the specific subjects covered by ERISA. The Conference Committee rejected those provisions in favor of the present language, and indicated that section’s pre-emptive scope was as broad as its language. See H.R.Conf.Rep. No. 93-1280, p. 383 (1974); S.Conf.Rep. No. 93-1090, p. 383 (1974).
It should be stressed that with the narrow exceptions specified in the bill, the substantive and enforcement provisions of the conference substitute are intended to preempt the field for Federal regulations, thus eliminating the threat of conflicting or inconsistent State and local regulation of employee benefit plans. This principle is intended to apply in its broadest sense to all actions of State or local governments, or any instrumentality thereof, which have the force or effect of law.
See
120 Cong.Rec. 29933 (1974).
See also Pilot Life,
.
Pilot Life,
. Amicus curiae Louisiana Trial Lawyers Association (LTLA) argues that United is not an ERISA fiduciary, and that therefore the tort claims against it cannot be pre-empted. The parties, however, agree that United is a fiduciary, and we have no reason to dispute this. United’s contract with Bell would appear to give it “discretionary authority or discretionary con
*1331
trol respecting management of [the] plan” or "authority or control respecting management or disposition of its assets ... [,]” thus satisfying the statutory definition of a fiduciary. 29 U.S.C. § 1002(21)(A)(i). In any event, all courts of appeals to have considered the issue have held that ERISA pre-emption may apply regardless of whether the defendant is a plan fiduciary.
Consolidated Beef Indus., Inc. v. New York Life Ins. Co.,
. It is the medical decisionmaking aspect of the utilization review process that has spawned the literature assessing the application of malpractice and other negligence-based doctrines to hold these entities liable for patient injuries. See Blum, supra, at 199 ("The overriding incentive for [utilization review] may be cost containment, but the process itself is triggered by a medical evaluation of a particular case, an evaluation that requires a clinical judgment.”) (footnote omitted); Tiano, supra, at 80 ("The patient faces conflicting judgments by two medical professionals: the treating physician and the utilization review consultant”); Chittenden, supra, at 476 ("negligent implementation of cost-control mechanisms may affect the medical judgment of the physician or other provider resulting in physical injury to the patient").
. See Comment, A Cost Containment Malpractice Defense: Implications for the Standard of Care and for Indigent Patients, 26 Hous.L.Rev. 1007, 1021 (1989) (by Leslie C. Giordani).
. We find
Independence HMO, Inc. v. Smith,
We also find
Eurine v. Wyatt Cafeterias,
No. 3-91-0408-H,
Finally, to the extent that two other decisions cited by the Corcorans,
Kohn v. Delaware Valley HMO, Inc.,
No. 91-2745,
. Section 502(a)(2) permits “the Secretary ... a participant, beneficiary or fiduciary" to sue for appropriate relief under § 409.
.
Drinkwater v. Metropolitan Life Ins. Co.,
. See J. Calamari & J. Perillo, The Law of Contracts §§ 14-3, 14-5(b), at 595-96 (3d ed. 1987); 11 W. Jaeger, Williston on Contracts § 1341, at 214 (3d ed. 1968); 5 Corbin on Contracts § 1076, at 426 (2d ed. 1964).
. We note that, were the Corcorans able to recover against United under state law, the contract between Bell and United indicates that United would bear the cost. However, the general application of a liability system to utilization review companies would ultimately result in increased costs to plans such as the Bell plan as it became more expensive for companies such as United to do business.
